File Download

There are no files associated with this item.

Supplementary

Conference Paper: Immunological superiority of 2-dose As04-hpv-16/18 vaccine schedule versus 2-dose and 3-dose schedules of 4vhpv at month36: a randomized, multicentre trial

TitleImmunological superiority of 2-dose As04-hpv-16/18 vaccine schedule versus 2-dose and 3-dose schedules of 4vhpv at month36: a randomized, multicentre trial
Authors
Lee, BWLiu, APYLeung, TFFong, SLFranck, TOh, HMLChan, PCRombo, LTan, NCRouzier, RDe Simoni, SSuryakiran, PHezareh, MFolschweiller, NThomas, FStruyf, F
Issue Date2016
Citation
The 2016 Meeting of the Asia-Oceania Research Organisation on Genital Infection and Neoplasia (AOGIN), Ashok Patliputra, Patna, India, 14-16 October 2016. How to Cite?
DescriptionConference Theme: HPV Vaccination + Screening = Cervical Cancer Elimination
Persistent Identifierhttp://hdl.handle.net/10722/226506

 

DC FieldValueLanguage
dc.contributor.authorLee, BW-
dc.contributor.authorLiu, APY-
dc.contributor.authorLeung, TF-
dc.contributor.authorFong, SL-
dc.contributor.authorFranck, T-
dc.contributor.authorOh, HML-
dc.contributor.authorChan, PC-
dc.contributor.authorRombo, L-
dc.contributor.authorTan, NC-
dc.contributor.authorRouzier, R-
dc.contributor.authorDe Simoni, S-
dc.contributor.authorSuryakiran, P-
dc.contributor.authorHezareh, M-
dc.contributor.authorFolschweiller, N-
dc.contributor.authorThomas, F-
dc.contributor.authorStruyf, F-
dc.date.accessioned2016-06-17T07:44:35Z-
dc.date.available2016-06-17T07:44:35Z-
dc.date.issued2016-
dc.identifier.citationThe 2016 Meeting of the Asia-Oceania Research Organisation on Genital Infection and Neoplasia (AOGIN), Ashok Patliputra, Patna, India, 14-16 October 2016.-
dc.identifier.urihttp://hdl.handle.net/10722/226506-
dc.descriptionConference Theme: HPV Vaccination + Screening = Cervical Cancer Elimination-
dc.languageeng-
dc.relation.ispartofAOGIN India 2016 (7th National Conference of Asia-Oceania Research Organisation on Genital Infection and Neoplasia, India)-
dc.titleImmunological superiority of 2-dose As04-hpv-16/18 vaccine schedule versus 2-dose and 3-dose schedules of 4vhpv at month36: a randomized, multicentre trial-
dc.typeConference_Paper-
dc.identifier.emailLiu, APY: apyliu@hku.hk-
dc.identifier.authorityLiu, APY=rp01357-
dc.identifier.hkuros258400-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats